Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


How Should Pharma Feel About Reform? It Depends Who You Ask

This article was originally published in RPM Report

Executive Summary

The PhRMA annual meeting took place just days before the make or break vote on health care reform. Here is a sampling of what speakers at that event said about how industry should feel about the legislation.

You may also be interested in...

PhRMA 2014: IP, Research, and Reputation

NIH research support, intellectual property protections, and restoring the drug industry’s image moved up on the list of podium priorities at the PhRMA annual meeting in Washington, DC.

Defense-to-Offense: PhRMA Readies to Protect Government Markets

White House budget targeting biopharma with new cuts hits just as the Pharmaceutical Research & Manufacturers of America’s annual meeting gets under way.

Job One for Big Pharma: Repositioning in DC Post-Health Care Reform

How Wall Street’s reaction to the impact of health care reform may help the pharmaceutical industry make sure it pays off in the long run.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts